NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: A potential mechanism of neurotoxicity

Journal of Neuroscience

Volumn 22, Issue 8, 2002, Pages 3070-3080

  Li, Qiang ^a,b   Clark, Suzanne ^a,b   Lewis, Darrell V ^a   Wilson, Wilkie A ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Cingulate cortex; Disinhibition; Interneurons; IPSCs; MK 801; NMDA receptor; Pyramidal cells

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE; BIOCYTIN; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TETRODOTOXIN;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CINGULATE GYRUS; CONTROLLED STUDY; DRUG EFFECT; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

EID: 0037092430     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-08-03070.2002     Document Type: Article

References (66)

1. Aitken PG, Balestrino M, Somjen GG (1988) NMDA antagonists: Lack of protective effect against hypoxic damage in CA1 region of hippocampal slice. Neurosci Lett 89:187-192.
2. Allen HL, Iversen LL (1990) Phencyclidine, dizocilpine and cerebrocortical neurons. Science 247:221.
3. Auer RN (1996) Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats. Stroke 27:743-746.
4. Auer RN (1997) Structural neurotoxicologic investigation of the glycine antagonist 5-nitro-6,7-dichloroquinoxalinedione (ACEA-1021). Neurotoxicology 18:53-62.
5. Avoli M, Oliver A (1987) Bursting in human epileptogenic neocortex is depressed by an N-methyl-D-aspartate antagonist. Neurosci Lett 76:249-258.
6. Bandrowski AE, Aramakis VB, Moore SL (2001) Metabotropic glutamate receptors modify ionotropic glutamate responses in neocortical pyramidal cells and interneurons. Exp Brain Res 136:25-40.
7. Berger P, Farrel K, Sharp F, Skolnick P (1994) Drugs acting at the strychnine-insensitive glycine receptor do not induce HSP-70 protein in the cingulate cortex. Neurosci Lett 168:147-150.
8. Boyce S, Wyatt A, Webb JK, O'Donnell R, Mason G, Rigby M, Sirinathsinghji D, Hill RG, Rupniak NM (1999) Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: Correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38:611-623.
9. Brennan PA, Keverne EB (1989) Impairment of olfactory memory by local infusions of non-selective excitatory amino acid receptor antagonists into the accessory olfactory bulb. Neuroscience 33:463-468.
10. Cohen GA, Doze VA, Madison DV (1992) Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron 9:325-335.
11. Colbourne F, Rakic D, Auer RN (1999) The effects of temperature and scopolamine on N-methyl-D-aspartate antagonist-induced neuronal necrosis in the rat. Neuroscience 90:87-94.
12. Corso TD, Sesma MA, Tenkova TI, Der TC, Wozniak DF, Farber NB, Olney JW (1997) Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res 752:1-14.
13. Dirnagl U, Tanabe J, Pulsinelli W (1990) Pre- and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat. Brain Res 527:62-68.
14. Ellison G (1995) The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Rev 20:250-267.
15. Farber NB, Foster J, Duhan NL, Olney JW (1995a) Alpha 2 adrenergic agonists prevent MK-801 neurotoxicity. Neuropsychopharmacology 12:347-349.
16. Farber NB, Wozniak DF, Price MT, Labruyere J, Huss J, St. Peter H, Olney JW (1995b) Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia? Biol Psychiatry 38:788-796.
17. Farber NB, Foster J, Duhan NL, Olney JW (1996) Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophrenia Res 21:33-37.
18. Feldmeyer D, Sakmann B (2000) Synaptic efficacy and reliability of excitatory connections between the principal neurons of the input (layer 4) and output layer (layer 5) of the neocortex. J Physiol (Lond) 525:31-39.
19. Fix AS, Horn JW, Writhman KA, Johnson CA, Long GG, Storts RW, Farber N, Wozniak DF, Olney JW (1993) Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex. Exp Neurol 123:204-215.
20. Fix AS, Wozniak DF, Truex LL, McEwen M, Miller JP, Olney JW (1995) Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex. Brain Res 696:194-204.
21. Ford LM, Sanberg PR, Norman AB, Fogelson MH (1989) MK-801 prevents hippocampal neurodegeneration in neonatal hypoxic-ischemic rats. Arch Neurol 46:1090-1096.
22. Foster AC, Gill R, Woodruff GN (1988) Neuroprotective effects of MK-801 in vivo: Selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J Neurosci 8:4745-4754.
23. Gloveli T, Iserhot C, Schmitz D, Castren E, Behr J, Heinemann U (1997) Systemic administration of the phencyclidine compound MK-801 affects stimulus-induced field potentials selectively in layer III of rat medial entorhinal cortex. Neurosci Lett 221:93-96.
24. Grunze HCR, Rainnie DG, Hasselmo ME, Barkai E, Hearn EF, McCarley RW, Greene RW (1996) NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 16:2034-2043.
25. Hablitz JJ, Langmoen IA (1986) N-methyl-D-aspartate receptor antagonist reduce synaptic excitation in the hippocampus. J Neurosci 6:102-106.
26. Hestrin S (1992) Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse. Nature 357:686-689.
27. A synaptic transmission in the hippocampus. J Neurosci 20:2470-2479.
28. Horvath ZC, Czopf J, Buzsaki G (1997) MK-801-induced neuronal damage in rats. Brain Res 753:181-195.
29. Jones RSG, Buhl EH (1993) Basket-like interneurons in layer II of the entorhinal cortex exhibit a powerful NMDA-mediated synaptic excitation. Neurosci Lett 149:35-39.
30. Kawaguchi Y (1995) Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer II/III of rat frontal cortex. J Neurosci 15:2638-2655.
31. Kawaguchi Y, Kubota Y (1996) Physiological and morphological identification of somatostatin- or vasoactive intestinal polypeptide-containing cells among GABAergic cell subtypes in rat frontal cortex. J Neurosci 16:2701-2715.
32. Kim HG, Connors BW (1993) Apical dendrites of the neocortex: Correlation between sodium- and calcium-dependent spiking and pyramidal cell morphology. J Neurosci 13:5301-5311.
33. Kurumaji A, McCulloch J (1990) Effects of unilateral intrahippocampal injection of MK-801 upon local cerebral glucose utilisation in conscious rats. Brain Res 518:342-346.
34. Li Q, Clark S, Wilson WA, Lewis DV (2000) MK-801, an NMDA receptor antagonist, modulates the inhibitory postsynaptic currents (IPSCs) in pyramidal neurons in the rat cingulate cortex. Soc Neurosci Abstr 29:431.
35. Loscher W, Honack D (1991) The novel, competitive N-methyl-D- aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: Attenuation by manipulation of dopamine, alpha-1 and serotonin 1A receptor. J Pharmacol Exp Ther 257:1146-1153.
36. Lubke J, Markram H, Frotscher, M, Sakmann B (1996) Frequency and dendrite distribution of autopses established by layer 5 pyramidal neurons in the developing rat neocortex: Comparison with synaptic innervation of adjacent neurons of the same class. J Neurosci 16:3209-3218.
37. MacDonald JW, Silverstein FS, Johnston MV (1990) MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate antagonist recognition site binding in rats. Neuroscience 38:103-113.
38. McBain CJ, Dingledine R (1993) Heterogeneity of synaptic glutamate receptors on CA3 stratum radiatum interneurones of rat hippocampus. J Physiol (Lond) 462:373-392.
39. Mott DD, Turner DA, Okazaki MM, Lewis DV (1997) Interneurons of the rat dentate gyrus: Morphological and electrophysiological heterogeneity. J Neurosci 17:3990-4005.
40. Mott DD, Li Q, Okazaki MM, Turner DA, Lewis DV (1999) GABAB- receptor-mediated currents in interneurons of the dentate-hilus border. J Neurophysiol 82:1438-1450.
41. Nehls DG, Park CK, MacCormack AG, McCulloch J (1990) The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisation. Brain Res 511:271-279.
42. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007.
43. Olney JW, Price MT, Labruyere J, Salles KS, Frierdich G, Mueller M, Silverman E (1987) Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur J Pharmacol 142:319-320.
44. Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362.
45. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA (1991) NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254:1515-1518.
46. Patel TR, McCulloch J (1995) AMPA receptor antagonism attenuates MK-801-induced hypermetabolism in the posterior cingulate cortex. Brain Res 686:254-258.
47. Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist: A review of preclinical data. Neuropharmacology 38:735-767.
48. Paxinos G, Watson C (1986) The Rat Brain in Stereotaxic Coordinates. New York: Academic.
49. Rainnie DG, Asprodini EK, Shinnick-Gallagher P (1991) Excitatory transmission in the basolateral amygdala. J Neurophysiol 66:986-998.
50. Reyes A, Sakmann B (1999) Developmental switch in the short-term modification of unitary EPSPs evoked in layer 2/3 and layer 5 pyramidal neurons of rat neocortex. J Neurosci 19:3827-3835.
51. Rod MR, Auer RN (1989) Pre- and post-ischemic administration of dizocilpine (MK-801) reduces cerebral necrosis in the rat. Can J Neurol Sci 16:340-344.
52. Rothman SM, Olney JW (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105-111.
53. Rothman SM, Olney JW (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci 10:299-302.
54. Salin PA, Prince DA (1996) Spontaneous GABAA receptor-mediated inhibitory currents in adult rat somatosensory cortex. J Neurophysiol 75:1573-1588.
55. Sams-Dodd F (1997) Effects of novel antipsychotic drugs on phencyclidine-induced stereotyped behavior and social isolation in the rat social interaction test. Behav Pharmacol 8:196-215.
56. Schoppa NE, Kinzie M, Sahara Y, Segerson TP, Westbrook GL (1998) Dendrodendritic inhibition in the olfactory bulb is driven by NMDA receptors. J Neurosci 18:6790-6802.
57. Sharp FR, Butman M, Aardalen K, Nickolenko J, Nakki R, Massa SM, Swanson A, Sagar SM (1994) Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics. Psychopharmacol Bull 30:555-560.
58. Sripanidkulchai K, Wyss JM (1987) The laminar organization of efferent neuronal cell bodies in the retrosplenial granular cortex. Brain Res 406:255-269.
59. Stasheff SF, Anderson WW, Clark S, Wilson WA (1989) NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Science 245:648-651.
60. Subramaniam S, Rho JM, Penix L, Donevan SD, Fielding RP, Rogawski MA (1995) Felbamate block of the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther 273:878-886.
61. Sveinbjornsdottir S, Sander JW, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan JS (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16:165-174.
62. Tomitaka S, Tomitaka M, Tolliver BK, Sharp FR (2000) Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex. Eur J Neurosci 12:1420-1430.
63. Vaisanen J, Linden AM, Lakso M, Wong G, Heinemann U, Castren E (1999) Excitatory actions of NMDA receptor antagonists in rat entorhinal cortex and cultured entorhinal cortical neurons. Neuropsycho-pharmacology 21:137-146.
64. Wieloch T (1985) Hypoglycemia-induced damage prevented by an N-methyl-D-aspartate antagonist. Science 230:681-683.
65. Wozniak DF, Brosnon-Watters G, Nardi A, McEwen M, Corso TD, Olney JW, Fix AS (1996) MK-801 neurotoxicity in male mice: Histologic effects and chronic impairment in spatial learning. Brain Res 707:165-179.
66. Zhou FM, Hablitz JJ (1998) AMPA receptor-mediated EPSCs in rat neocortical layer II/III interneurons have rapid kinetics. Brain Res 780:166-169.